• 08 Aug 25

Scaling for growth: IXICO’s financial outlook and market opportunities - P4

Scaling for growth: IXICO’s financial outlook and market opportunities - P4

IXICO Plc | IXI | 11.5 0 0%

    • 60 views

 

In the final segment, CEO Bram Goorden covers IXICO PLC (LSE:IXI, OTC:PHYOF)’s strong order book, revenue visibility, and growing pipeline of Alzheimer’s projects. Learn why the company sees significant opportunities for partnerships and expansion into new verticals.

Click the link in the video, or visit the IXICO profile to view the full interview.

#Neuroscience #CNS #Biomarkers #ClinicalResearch #LifeSciences #IXICO #Neuroimaging #AlzheimersResearch #ParkinsonsDisease #AIDrivenHealthcare #Biomarkers #ClinicalResearch #HealthcareInnovation #UKStocks #BramGoorden #ProactiveInvestors #MedicalAI #LifeSciences #PostMarketingSurveillance #AI #AIinHealthcare #Alzheimers #Parkinsons #BiotechInnovation

Enjoying this article?

Get a £25 credit by sharing with your friends and colleagues via our Refer a Friend page. Each new subscriber gets a 10% discount and you get a free month off your bill every time.


Don't worry, if you're a Lite-Access/Free user we save all your credits for the day you decide to fully subscribe.


 

IXICO CEO discusses significance of two major neuroimaging contract wins

Companies: IXICO Plc

IXICO CEO on strong H1 performance, diversification and new verticals

Companies: IXICO Plc

IXICO, Polarean Imaging, Great Southern Copper, Rome Resources, Thor Explorations, Valereum - Small Cap Snapshot

Companies: IXICO Plc

IXICO mark 'fifth year of successive EBITDA growth' and hail 'great market opportunity ahead'

Companies: IXICO Plc

AI at the heart: IXICO’s technology roadmap for the future - P3

Companies: IXICO Plc

IXICO PLC to post its first annual underlying profit since listing

Companies: IXICO Plc

© Research Tree 2025

  • Apple Store
  • Play Store

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top